| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |